As a service to the SITC membership and the oncology community as a whole, SITC offers FREE, CME-certified online education on the topic of immunotherapy through Clinical Advances in Immuno-Oncology, a robust online learning center. Developed through a partnership with Medscape Oncology, this learning center is designed to provide education to oncologists in a variety of immunotherapy related topics beginning with immunology fundamentals and advancing to tumor-specific immunotherapy education.
As a new addition, SITC has also partnered with Medscape to offer Patient Education activities for patients, caregivers, or those interested in learning more about specific types of cancer and how immunotherapy can be used for them. To access the patient education activities, please scroll to the bottom of the page!
To access each CME educational activity, click on the topics below.
Please note: you will be prompted to log-in to Medscape. If you don't have an account, you can create one for free.
Determining the Best Treatment Algorithm for Patients With Head and Neck Cancer |
|
Strengthening Lung Cancer Team Connections to Improve Outcomes With Immunotherapy |
|
Clinical Challenges in Melanoma: Progressive Disease |
|
New Frontiers in Decision Making: Immunotherapy in Advanced Non-Squamous NSCLC |
|
New Frontiers in Decision Making: Adverse Events With Immunotherapy in NSCLC |
|
Essential Concepts in Harnessing the Immune System in Head and Neck Cancer |
|
The Nurse View: Overcoming Challenges Associated with Cancer Immunotherapy |
|
Clinical Challenges in Melanoma: Frontline |
|
New Frontiers in Decision Making: Immunotherapy in Advanced Squamous Cell NSCLC |
|
Changing the Paradigm of Treatment in Patients With Hodgkin Lymphoma |
|
Patient-Centered Care in Metastatic Renal Cell Carcinoma |
|
Priming T-Cells: Do We Understand the Strategies? |
|
Emerging Considerations in the Use of Immune Checkpoints in Lung Cancer |
|
Spotlight on Immuno-Oncology in Melanoma |
|
Pulmonologist Perspectives: How Will the Use of Immune Checkpoint Inhibitors Affect My Practice? |
|
Hiding in Plain Sight: How Cancer Evades the Immune System |
|
Cancer Immunotherapy: Pathways and Mechanisms of Actions |
|
Clinical Considerations in the Use of Checkpoint Inhibitors for Gastrointestinal |
|
Clinical Considerations in the Use of Checkpoint Inhibitors -- Genitourinary |
|
Integrating Novel Immunotherapies in the Management of Advanced NSCLC February 22, 2016 Drs. Chaft and Hellmann review tailored treatment approaches for patients with advanced NSCLC. |
|
Clinical Considerations in the Use of Checkpoint Inhibitors -- Breast Cancer January 26, 2016 Drs. Burris and Yee talk about immunotherapy and how this new therapeutic class is being developed for patients with breast cancer. |
Additional activities are available in our archive. While these activities are no longer CME-certified, they remain valuable resources for oncologists interested in learning more about cancer immunotherapy. Access the archive.
Is Immunotherapy Right for My Lung Cancer? |
|
Immunotherapy Side Effects: Talking With Your Melanoma Care Team |
Is Immunotherapy for Lung Cancer the Same Thing as Chemotherapy? |
|
What Treatment Is Right for My Metastatic Melanoma? |
|